To be appointed to, and to remain on, a CLAE committee, an individual must be a member of CLAE in good standing. Appointments to the committees are selected from among self-nominations or nominations made by other CLAE members. Considerations in selecting committee members may include the need for expertise in a certain area or for geographic representation across Canada.
Awards Committee - This committee is tasked primarily with selecting the winners of the following CLAE awards: (1) Penfield Lifetime Achievement Award; (2) Junior Investigator Award; (3) Excellence in Research Awards; and (4) Excellence in Clinical Practice/Advocacy Award. The committee will also be tasked with selecting the winners of the 4 trainee/allied health professional publication awards: (1) Mary Ann Lee Award (for resident); (2) Medical student/graduate student Award; (3) Fellow/post graduate student Award; and (4) Allied health professional Award. Finally, when funding is available, this committee will select the clinical fellowship in epilepsy awardee. The committee reports directly to the CLAE executive board of directors. The chair is selected by the nominating committee.
Fundraising Committee - The primary role of this committee is to develop strategies and potential campaigns to raise funds for the CLAE. The funds will be used mainly to promote education and research (e.g. epilepsy fellowships, studentships, pilot grants, etc.) The committee could work in conjunction with other organizations to enhance fundraising if the fundraising goals of these two organizations are aligned. The committee will report to the CLAE executive board of directors. The chair is the Treasurer of the CLAE (elected).
Publication Committee - This committee is tasked primarily with the publication of the official newsletter of the CLAE, ‘CLAE Connections’. The committee will be responsible for implementing appropriate changes to the template of the current newsletter to reflect the information needs of broader membership. The committee will also be tasked with selecting the appropriate content and identifying members who will be profiled in each edition. The committee reports directly to the CLAE executive board of directors. The chair is selected by the nominating committee.
Medical Therapeutics Committee – The primary aim of the therapeutics committee is to improve patient access to evidence-based treatments for epilepsy. In this regard this Committee will provide information and guidance to the CLAE executive board on matters that prevent people with epilepsy from receiving or gaining access to appropriate treatment. A key role of this task force is to gather relevant information in order to understand a particular concern in the Canadian context, including possible provincial/territorial, federal and/or international factors, and to develop potential strategies to address treatment disparities. An important part of this mandate is to develop improved communication between the epilepsy community and Provincial and Federal Drug programs as well as improved education of our own community regarding these issues. The chair of the committee will be appointed by the CLAE executive board.
Driving and Epilepsy Task Force - This task force’s overarching aim is to develop consensus statements for the CLAE that promote more effective, scientifically valid, and harmonious driving assessment and restriction mechanisms for patients with seizures or epilepsy across Canada. The goal will not be to develop new driving guidelines but rather is to work towards enhancing the harmonization of existing provincial and national guidelines. In consultation with the wider CLAE membership, points of consensus will be identified by the committee and brought forward for approval by executive. The committee will require broad geographic representation and will also require diversity in stakeholders (e.g. patient, physician and other allied health professionals). Collaboration with national groups involved in developing provincial or national guidelines will also be sought to increase the likelihood of harmonizing recommendations nationally. The chair of the committee will be appointed by the CLAE executive board.
Nomination Committee - The main goal of this CLAE committee should be to produce an effective volunteer leadership team, through an open nomination process to facilitate the representation of fresh ideas within the leadership, along with maintaining optimal continuity and insight into the CLAE's needs and functions. A further goal of this process is to ensure representation on the Executive Board that reflects membership diversity. This committee will select CLAE members who will be part of the different CLAE committees based on nominations received. These members can either be nominated by other CLAE members or can be self-nominated. The nominating committee will aim (as much as possible depending on the number of nominations) to select members on different CLAE committees that are broadly representative (geographically, expertise, etc.). The committee is composed of 5 CLAE members, and is chaired by the President-Elect for a total of 2 years. Members will sit on this committee for a 2-year term. Should one of these individuals be unable to perform the assigned duties, the Nominating Committee Chair will appoint additional committee members so that there shall always be at least 3 members. Members who complete their initial term can be re-elected for a second and final 2-year term.